QDEL / QuidelOrtho's (QDEL) Rapid Antigen Test Gets De Novo FDA Approval

The headline numbers for QuidelOrtho (QDEL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile more_horizontal

QuidelOrtho benefited from the pandemic, using proceeds to buy back shares and announce a large deal. The acquisition of Ortho Clinical Diagnostics ad more_horizontal

QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock. more_horizontal

QuidelOrtho (QDEL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement amon more_horizontal

Despite solid performances by the Labs segment and Other region, QuidelOrtho (QDEL) reports soft overall top-line results in second-quarter 2023. more_horizontal

Although the revenue and EPS for QuidelOrtho (QDEL) give a sense of how its business performed in the quarter ended June 2023, it might be worth consi more_horizontal

QuidelOrtho Corporation (NASDAQ:QDEL ) Q2 2023 Earnings Call August 8, 2023 5:00 PM ET Company Participants Bryan Brokmeier - Vice President of Invest more_horizontal

The consensus price target hints at a 29.9% upside potential for QuidelOrtho (QDEL). While empirical research shows that this sought-after metric is h more_horizontal